Enhanced formation and impaired degradation of neutrophil extracellular traps in dermatomyositis and polymyositis: a potential contributor to interstitial lung disease complications
Tóm tắt
Dermatomyositis (DM) and polymyosits (PM) are systemic autoimmune diseases whose pathogeneses remain unclear. Neutrophil extracellular traps (NETs) are reputed to play an important role in the pathogenesis of autoimmune diseases. This study tests the hypothesis that NETs may be pathogenic in DM/PM. Plasma samples from 97 DM/PM patients (72 DM, 25 PM) and 54 healthy controls were tested for the capacities to induce and degrade NETs. Plasma DNase I activity was tested to further explore possible reasons for the incomplete degradation of NETs. Results from 35 DM patients and seven PM patients with interstitial lung disease (ILD) were compared with results from DM/PM patients without ILD. Compared with control subjects, DM/PM patients exhibited a significantly enhanced capacity for inducing NETs, which was supported by elevated levels of plasma LL-37 and circulating cell-free DNA (cfDNA) in DM/PM. NETs degradation and DNase I activity were also decreased significantly in DM/PM patients and were correlated positively. Moreover, DM/PM patients with ILD exhibited the lowest NETs degradation in vitro due to the decrease in DNase I activity. DNase I activity in patients with anti-Jo-1 antibodies was significantly lower than in patients without. Glucocorticoid therapy seems to improve DNase I activity. Our findings demonstrate that excessively formed NETs cannot be degraded completely because of decreased DNase I activity in DM/PM patients, especially in patients with ILD, suggesting that abnormal regulation of NETs may be involved in the pathogenesis of DM/PM and could be one of the factors that initiate and aggravate ILD.
Từ khóa
Tài liệu tham khảo
Zong, 2011, Pathogenesis, classification and treatment of inflammatory myopathies, Nat Rev Rheumatol, 7, 297, 10.1038/nrrheum.2011.39
Dalakas, 2012, Pathogenesis and therapies of immune-mediated myopathies, Autoimmun Rev, 11, 203, 10.1016/j.autrev.2011.05.013
Danoff, 2011, The lung as a possible target for the immune reaction in myositis, Arthritis Res Ther, 13, 230, 10.1186/ar3347
Hirakata, 2000, Interstitial lung disease in polymyositis and dermatomyositis, Curr Opin Rheumatol, 12, 501, 10.1097/00002281-200011000-00005
Cheng, 2013, NET balancing: a problem in inflammatory lung diseases, Front Immunol, 4, 1, 10.3389/fimmu.2013.00001
Khandpur, 2013, NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis, Sci Transl Med, 5, 178ra40, 10.1126/scitranslmed.3005580
Keshari, 2012, Cytokines induced neutrophil extracellular traps formation: implication for the inflammatory disease condition, PLOS ONE, 7, e48111, 10.1371/journal.pone.0048111
Hakkim, 2010, Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis, Proc Natl Acad Sci USA, 107, 9813, 10.1073/pnas.0909927107
Villanueva, 2011, Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus, J Immunol, 187, 538, 10.4049/jimmunol.1100450
Leffler, 2012, Neutrophil extracellular traps that are not degraded in systemic lupus erythematosus activate complement exacerbating the disease, J Immunol, 188, 3522, 10.4049/jimmunol.1102404
Kessenbrock, 2009, Netting neutrophils in autoimmune small-vessel vasculitis, Nat Med, 15, 623, 10.1038/nm.1959
Manzenreiter, 2012, Ultrastructural characterization of cystic fibrosis sputum using atomic force and scanning electron microscopy, J Cyst Fibros, 11, 84, 10.1016/j.jcf.2011.09.008
Thomas, 2012, Extracellular DNA traps are associated with the pathogenesis of TRALI in humans and mice, Blood, 119, 6335, 10.1182/blood-2012-01-405183
Caudrillier, 2012, Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury, J Clin Invest, 122, 2661, 10.1172/JCI61303
Brinkmann, 2004, Neutrophil extracellular traps kill bacteria, Science, 303, 1532, 10.1126/science.1092385
Fuchs, 2007, Novel cell death program leads to neutrophil extracellular traps, J Cell Biol, 176, 231, 10.1083/jcb.200606027
Liu, 2012, Specific post-translational histone modifications of neutrophil extracellular traps as immunogens and potential targets of lupus autoantibodies, Arthritis Res Ther, 14, R25, 10.1186/ar3707
Saffarzadeh, 2012, Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones, PLOS ONE, 7, e32366, 10.1371/journal.pone.0032366
Xu, 2009, Extracellular histones are major mediators of death in sepsis, Nat Med, 15, 1318, 10.1038/nm.2053
Garcia-Romo, 2011, Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus, Sci Transl Med, 3, 73ra20, 10.1126/scitranslmed.3001201
Lande, 2011, Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus, Sci Transl Med, 3, 73ra19, 10.1126/scitranslmed.3001180
Bosch, 2011, Systemic lupus erythematosus and the neutrophil, N Engl J Med, 365, 758, 10.1056/NEJMcibr1107085
Bohan, 1975, Polymyositis and dermatomyositis (first of two parts), N Engl J Med, 292, 344, 10.1056/NEJM197502132920706
Bohan, 1975, Polymyositis and dermatomyositis (second of two parts), N Engl J Med, 292, 403, 10.1056/NEJM197502202920807
Rider, 2011, Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI), Arthritis Care Res (Hoboken), 63, S118, 10.1002/acr.20532
Macanovic, 1997, Measurement of deoxyribonuclease I (DNase) in the serum and urine of systemic lupus erythematosus (SLE)-prone NZB/NZW mice by a new radial enzyme diffusion assay, Clin Exp Immunol, 108, 220, 10.1046/j.1365-2249.1997.3571249.x